Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
Spleen tyrosine kinase (SYK) is an important regulatory molecule of signal transduction pathways involved in the pathogenesis of autoimmune diseases such as immune thrombocytopenia (ITP), and the SYK-signaling pathway has emerged as a potential target for the treatment of numerous diseases. The aim...
Main Authors: | Nichola Cooper, Waleed Ghanima, Quentin A Hill, Phillip LR Nicolson, Vadim Markovtsov, Craig Kessler |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-01-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2022.2131751 |
Similar Items
-
Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs
by: Maan H. Harbi, et al.
Published: (2022-06-01) -
Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach
by: Sina Sender, et al.
Published: (2022-09-01) -
The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases
by: Yaping Zhao, et al.
Published: (2022-12-01) -
The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis
by: Eszter Káposztás, et al.
Published: (2023-12-01) -
Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets
by: Pankaj Kumar Singh, et al.
Published: (2023-12-01)